GO:0006521 | regulation of cellular amino acid metabolic process | 3.99e-09 | 3.89e-05 | 7.311 | 4 | 16 | 41 |
GO:0000502 | proteasome complex | 7.02e-09 | 6.85e-05 | 7.114 | 4 | 17 | 47 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.06e-08 | 1.04e-04 | 6.968 | 4 | 17 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.15e-08 | 1.12e-04 | 6.941 | 4 | 17 | 53 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.44e-08 | 1.41e-04 | 6.861 | 4 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.55e-08 | 1.51e-04 | 6.836 | 4 | 16 | 57 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.91e-08 | 1.87e-04 | 6.762 | 4 | 17 | 60 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.05e-08 | 2.00e-04 | 6.738 | 4 | 16 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.66e-08 | 2.59e-04 | 6.646 | 4 | 17 | 65 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.59e-08 | 3.51e-04 | 6.539 | 4 | 16 | 70 |
GO:0022624 | proteasome accessory complex | 4.68e-08 | 4.57e-04 | 8.446 | 3 | 7 | 14 |
GO:0000209 | protein polyubiquitination | 1.09e-07 | 1.07e-03 | 6.145 | 4 | 16 | 92 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.86e-07 | 1.82e-03 | 5.954 | 4 | 18 | 105 |
GO:0043066 | negative regulation of apoptotic process | 2.21e-07 | 2.16e-03 | 4.659 | 5 | 20 | 322 |
GO:0042981 | regulation of apoptotic process | 2.42e-07 | 2.36e-03 | 5.861 | 4 | 18 | 112 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.76e-07 | 3.68e-03 | 5.703 | 4 | 24 | 125 |
GO:0016032 | viral process | 9.15e-07 | 8.93e-03 | 4.249 | 5 | 32 | 428 |
GO:0016071 | mRNA metabolic process | 1.29e-06 | 1.26e-02 | 5.259 | 4 | 21 | 170 |
GO:0016070 | RNA metabolic process | 1.94e-06 | 1.89e-02 | 5.114 | 4 | 21 | 188 |
GO:0005838 | proteasome regulatory particle | 1.41e-05 | 1.38e-01 | 8.347 | 2 | 4 | 10 |
GO:0000278 | mitotic cell cycle | 1.50e-05 | 1.46e-01 | 4.374 | 4 | 35 | 314 |
GO:0006915 | apoptotic process | 4.34e-05 | 4.24e-01 | 3.985 | 4 | 21 | 411 |
GO:0010467 | gene expression | 1.22e-04 | 1.00e+00 | 3.605 | 4 | 31 | 535 |
GO:0016020 | membrane | 1.54e-04 | 1.00e+00 | 2.753 | 5 | 38 | 1207 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0044281 | small molecule metabolic process | 7.21e-04 | 1.00e+00 | 2.947 | 4 | 32 | 844 |
GO:0005654 | nucleoplasm | 8.33e-04 | 1.00e+00 | 2.894 | 4 | 55 | 876 |
GO:0005829 | cytosol | 1.04e-03 | 1.00e+00 | 2.187 | 5 | 58 | 1787 |
GO:0006458 | 'de novo' protein folding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0016887 | ATPase activity | 1.52e-03 | 1.00e+00 | 5.025 | 2 | 6 | 100 |
GO:0003688 | DNA replication origin binding | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0046696 | lipopolysaccharide receptor complex | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0043248 | proteasome assembly | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 4 | 6 |
GO:0043032 | positive regulation of macrophage activation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0032727 | positive regulation of interferon-alpha production | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0001530 | lipopolysaccharide binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0042026 | protein refolding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0032465 | regulation of cytokinesis | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0051131 | chaperone-mediated protein complex assembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0030234 | enzyme regulator activity | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0006200 | ATP catabolic process | 7.08e-03 | 1.00e+00 | 3.894 | 2 | 8 | 219 |
GO:0048863 | stem cell differentiation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0032733 | positive regulation of interleukin-10 production | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0042176 | regulation of protein catabolic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0070064 | proline-rich region binding | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0050870 | positive regulation of T cell activation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0070062 | extracellular vesicular exosome | 8.95e-03 | 1.00e+00 | 1.988 | 4 | 43 | 1641 |
GO:1903506 | regulation of nucleic acid-templated transcription | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 16 |
GO:0042113 | B cell activation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 16 |
GO:0005839 | proteasome core complex | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 9 | 16 |
GO:0042100 | B cell proliferation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0004298 | threonine-type endopeptidase activity | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 9 | 17 |
GO:0005844 | polysome | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0032735 | positive regulation of interleukin-12 production | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 20 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0032755 | positive regulation of interleukin-6 production | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 27 |
GO:0032729 | positive regulation of interferon-gamma production | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 28 |
GO:0042110 | T cell activation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 33 |
GO:0006986 | response to unfolded protein | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 35 |
GO:0005905 | coated pit | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 37 |
GO:0000932 | cytoplasmic mRNA processing body | 2.61e-02 | 1.00e+00 | 5.242 | 1 | 2 | 43 |
GO:0030141 | secretory granule | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 44 |
GO:0051087 | chaperone binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 45 |
GO:0003725 | double-stranded RNA binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 45 |
GO:0002039 | p53 binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 45 |
GO:0051301 | cell division | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 3 | 49 |
GO:0003697 | single-stranded DNA binding | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 6 | 57 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 1 | 61 |
GO:0007010 | cytoskeleton organization | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 1 | 61 |
GO:0050821 | protein stabilization | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 1 | 64 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.05e-02 | 1.00e+00 | 4.602 | 1 | 2 | 67 |
GO:0008360 | regulation of cell shape | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 1 | 70 |
GO:0051082 | unfolded protein binding | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 4 | 70 |
GO:0016363 | nuclear matrix | 4.40e-02 | 1.00e+00 | 4.479 | 1 | 7 | 73 |
GO:0005515 | protein binding | 5.22e-02 | 1.00e+00 | 0.981 | 5 | 76 | 4124 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 5.52e-02 | 1.00e+00 | 4.145 | 1 | 2 | 92 |
GO:0016477 | cell migration | 5.76e-02 | 1.00e+00 | 4.083 | 1 | 2 | 96 |
GO:0005769 | early endosome | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 1 | 109 |
GO:0006397 | mRNA processing | 6.57e-02 | 1.00e+00 | 3.887 | 1 | 2 | 110 |
GO:0007049 | cell cycle | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 3 | 115 |
GO:0016607 | nuclear speck | 7.27e-02 | 1.00e+00 | 3.738 | 1 | 3 | 122 |
GO:0044822 | poly(A) RNA binding | 8.04e-02 | 1.00e+00 | 2.026 | 2 | 25 | 799 |
GO:0003714 | transcription corepressor activity | 8.13e-02 | 1.00e+00 | 3.570 | 1 | 2 | 137 |
GO:0005759 | mitochondrial matrix | 8.24e-02 | 1.00e+00 | 3.550 | 1 | 5 | 139 |
GO:0008380 | RNA splicing | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 7 | 165 |
GO:0005524 | ATP binding | 9.76e-02 | 1.00e+00 | 1.868 | 2 | 23 | 892 |
GO:0005634 | nucleus | 9.92e-02 | 1.00e+00 | 1.004 | 4 | 67 | 3246 |
GO:0003713 | transcription coactivator activity | 1.08e-01 | 1.00e+00 | 3.145 | 1 | 5 | 184 |
GO:0005743 | mitochondrial inner membrane | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 3 | 197 |
GO:0043065 | positive regulation of apoptotic process | 1.18e-01 | 1.00e+00 | 3.010 | 1 | 3 | 202 |
GO:0043234 | protein complex | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 8 | 210 |
GO:0005813 | centrosome | 1.26e-01 | 1.00e+00 | 2.907 | 1 | 8 | 217 |
GO:0003723 | RNA binding | 1.43e-01 | 1.00e+00 | 2.720 | 1 | 11 | 247 |
GO:0005730 | nucleolus | 1.66e-01 | 1.00e+00 | 1.419 | 2 | 41 | 1217 |
GO:0009986 | cell surface | 1.66e-01 | 1.00e+00 | 2.484 | 1 | 2 | 291 |
GO:0005615 | extracellular space | 3.39e-01 | 1.00e+00 | 1.322 | 1 | 8 | 651 |
GO:0005739 | mitochondrion | 3.43e-01 | 1.00e+00 | 1.304 | 1 | 11 | 659 |
GO:0005737 | cytoplasm | 5.12e-01 | 1.00e+00 | 0.306 | 2 | 50 | 2633 |
GO:0005886 | plasma membrane | 7.02e-01 | 1.00e+00 | -0.132 | 1 | 11 | 1784 |